Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1970.65-0.1 (-0.01 %)

PREV CLOSE ( ) 1970.75

OPEN PRICE ( ) 1971.25

BID PRICE (QTY) 1973.75 (6)

OFFER PRICE (QTY) 1975.85 (6)

VOLUME 2717

TODAY'S LOW / HIGH ( )1947.85 1995.10

52 WK LOW / HIGH ( )1200 2220.95

NSE1973.802.9 (+0.15 %)

PREV CLOSE( ) 1970.90

OPEN PRICE ( ) 1987.20

BID PRICE (QTY) 1973.70 (8)

OFFER PRICE (QTY) 1974.80 (2)

VOLUME 104521

TODAY'S LOW / HIGH( ) 1948.00 2000.90

52 WK LOW / HIGH ( )1277.8 2220.95

Chairman	Srinivas Sadu
Company Secretary	Sampath Kumar Pallerlamudi
Non Executive Director	Allen Zhang
Independent Director	Wenjie Zhang
Non Executive Independent Director	Naina Lal Kidwai Udo Jahannes Vetter Satyanarayana Murthy Chavali Essaji Goolam Vahanvati
Non Independent & Non Executive Director	Wei Huang

Incorporation Year : 20-03 1978

Registered Office :

Address : Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal- Malkajgiri District Hyderabad,
Telangana-500043 .

Phone : 040 30510999

Email : gland@glandpharma.com / investor@glandpharma.com

URL : www.glandpharma.com

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

Risk Disclosures on Derivatives

Company Information

GLAND PHARMA LTD.